Cited by 1,030Genetic Neurodegenerative DiseasesMitochondrial Function and PathologyHereditary Neurological Disorders

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Panov, Alexander V., Gutekunst, Claire-Anne, Leavitt, Blair R., Hayden, Michael R., Burke, James R., Strittmatter, Warren J., Greenamyre, J. Timothy·2002·Nature Neuroscience

DOI 10.1038/nn884

Open this paper in CoChat — free account

Abstract

Huntington's disease (HD) is caused by an expansion of exonic CAG triplet repeats in the gene encoding huntingtin protein (Htt), but the mechanisms by which this mutant protein causes neurodegeneration remain unknown. Here we show that lymphoblast mitochondria from patients with HD have a lower membrane potential and depolarize at lower calcium loads than do mitochondria from controls. We found a similar defect in brain mitochondria from transgenic mice expressing full-length mutant huntingtin, and this defect preceded the onset of pathological or behavioral abnormalities by months. By electron microscopy, we identified N-terminal mutant huntingtin on neuronal mitochondrial membranes, and by incubating normal mitochondria with a fusion protein containing an abnormally long polyglutamine repeat, we reproduced the mitochondrial calcium defect seen in human patients and transgenic animals. Thus, mitochondrial calcium abnormalities occur early in HD pathogenesis and may be a direct effect of mutant huntingtin on the organelle.

Integrity signals

Registry

Crossref · 10.1038/nn884

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
Self-citation
A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,188
Mitochondrial Transport of Cations: Channels, Exchangers, and Permeability Transition
Bernardi, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1127 · Cited by 1,546
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434
Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo
Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291 · cited 1×
“Consistent with the toxic 'gain-of-function' hypothesis, mutant Htt self-associates and forms aggregates in a polyglutamine length–dependent manne”
Background
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
Steffan, J. S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B. L., Kazantsev, A., Schmidt, E., Zhu, Y.-Z., Greenwald, M., et al. (2001) · Nature · doi:10.1038/35099568 · Cited by 1,228
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123
Self-citation

Show all 35 references

Sorted by citations

Items 801–900 of 1,000

The Use of the Mitochondrial Toxin 3-NP to Uncover Cellular Dysfunction in Huntington’s Disease
Hernández, E., la Rosa-Lpez, G. D., & Mendoza, E. (2012) · InTech eBooks · doi:10.5772/31284 · Cited by 6
Consequences of Mitochondrial Dysfunction in Huntington's Disease and Protection via Phosphorylation Pathways
Cunha‐Oliveira, T., Lusa, I., & Cristina, A. (2012) · InTech eBooks · doi:10.5772/32728 · Cited by 6
Alleviating neurodegeneration in Drosophila models of PolyQ diseases
Long, Z., Tang, B., & Jiang, H. F. (2014) · Cerebellum & Ataxias · doi:10.1186/2053-8871-1-9 · Cited by 6
SSRs as Genetic Markers in the Human Genome and their Observable Relationship to Hereditary Diseases
Pai, T., & Chen, C. (2016) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0094 · Cited by 6
Post-Translational Modifications of Huntingtin: Mechanistic Insights and Therapeutic Opportunities in Huntington’s Disease
Zhang, X., Zhang, S., & Wang, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262210907 · Cited by 5
Altered mitochondrial Ca2+ uptake in presynaptic terminals of cultured striatal and cortical neurons from the zQ175 knock-in mouse model of Huntington's disease
Yoo, H., & Park, H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150010 · Cited by 5
Signaling Pathways Concerning Mitochondrial Dysfunction: Implications in Neurodegeneration and Possible Molecular Targets
Sharma, Y., Gupta, J. K., Babu, M. A., Singh, S., & Sindhu, R. K. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02269-5 · Cited by 6
Analysis of mitochondrial DNA variations in a Chinese family with spinocerebellar ataxia
Zeng, A., Liu, X., Shen, L., Li, W., Ding, Z., Bai, Y., & Lü, J. (2011) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2011.05.011 · Cited by 5
Hypergonadotropic Hypogonadism, Progressive Early-Onset Spinocerebellar Ataxia, and Late-Onset Sensorineural Hearing Loss: Case Report and Literature Review
Sarıkaya, E., Ensert, C., & Gülerman, H. F. (2011) · Balkan Journal of Medical Genetics · doi:10.2478/v10034-011-0050-z · Cited by 5
The Ageing Brain, Mitochondria and Neurodegeneration
Hudson, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-28637-2_3 · Cited by 5
Calcium-Mediated Calpain Activation and Microtubule Dissociation in Cell Model of Hereditary Sensory Neuropathy Type-1 Expressing V144D SPTLC1 Mutation
Antony, A., Ng, N. S., Lauto, A., Coorssen, J. R., & Myers, S. J. (2022) · DNA and Cell Biology · doi:10.1089/dna.2021.0816 · Cited by 5
Maladie de Huntington : aspects diagnostiques actuels et applications pratiques
Youssov, K., & Bachoud‐Lévi, A. (2008) · Encyclopédie médico-chirurgicale. Neurologie · doi:10.1016/s0246-0378(07)27525-6 · Cited by 5
Role of Mitochondria in Neurodegenerative Diseases: The Dark Side of the “Energy Factory”
Correia, S. C., & Moreira, P. I. (2018) · Springer eBooks · doi:10.1007/978-3-319-73344-9_11 · Cited by 5
The phasor FLIM method reveals a link between a change in energy metabolism and mHtt protein spread in healthy Mammalian cells when co-cultured with Huntington diseased cells
Sameni, S., Zhang, R., & Digman, M. A. (2020) · Methods and Applications in Fluorescence · doi:10.1088/2050-6120/ab854d · Cited by 5
Glutamine/Asparagine-Rich Regions in Proteins and Polyglutamine Diseases
Okazawa, H. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_22 · Cited by 5
Mitochondrial impairment induced by 3-nitropropionic acid is enhanced by endogenous metalloprotease activity inhibition in cultured rat striatal neurons
Balderas, P. M. D. O., Gutiérrez‐Ospina, G., & del Ángel, A. S. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.04.041 · Cited by 5
Restoring energy in a power crisis: mitochondrial targets for drug development
Howell, N., Taylor, S. W., Fahy, E., Murphy, A. N., & Ghosh, S. S. (2003) · TARGETS · doi:10.1016/s1477-3627(03)02364-x · Cited by 5
In Vitro Study of Caecal and Colon Microbial Fermentation Patterns in Wild Boar (Sus scrofa scrofa)
Pecka-Kiełb, E., Bujok, J., Miśta, D., Króliczewska, B., Górecka, J., & Zawadzki, W. (2016) · Folia Biologica · doi:10.3409/fb64_1.31 · Cited by 5
Huntington Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50018-8 · Cited by 5
Mitophagy in neurodegeneration: crosstalk between PRKN/parkin-dependent and PRKN-independent pathways
Rasmussen, L. K., Moreira, D. G., Okarmus, J., Simonsen, A., & Meyer, M. (2026) · Autophagy · doi:10.1080/15548627.2026.2711596 · Cited by 4
Huntington’s disease and mitochondrial alterations: emphasis on experimental models
de la Cruz, V. P., Carrillo-Mora, P. U., & Santamarı́a, A. (2010) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-010-9289-4 · Cited by 4
The Inverse Comorbidity between Oncological Diseases and Huntington’s Disease: Review of Epidemiological and Biological Evidence
Gomboeva, D. E., Bragina, E. Y., Nazarenko, M. S., & Puzyrev, V. P. (2020) · Russian Journal of Genetics · doi:10.1134/s1022795420030059 · Cited by 4
Neuroprotective effects of farnesol on motor and cognitive impairment against 3- nitropropionic acid-induced Huntington’s disease
Deepa, S., Rymbai, E., Praveen, T. K., & Saravanan, J. (2021) · The Thai Journal of Pharmaceutical Sciences · doi:10.56808/3027-7922.2468 · Cited by 4
A Systems Biology Approach to Investigating Apoptotic Stimuli as Effectors of Cell Metabolism: Practical Application of Top-Down Control Analysis to Attached Neurons
Jekabsons, M. B. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10020702 · Cited by 4
Mitochondrial Dysfunction and Molecular Bases of Neurodegenerative Diseases
Kolesnikova, E. E. (2013) · Neurophysiology · doi:10.1007/s11062-013-9341-1 · Cited by 4
Store-operated calcium entry into SK-N-SH human neuroblastoma cells modeling huntington’s disease
Vigont, V. A., Zimina, O. A., Глушанкова, Л. Н., Борисович, Б. И., Mozhayeva, G. N., & Kaznacheyeva, E. V. (2012) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s199074781201014x · Cited by 4
Integrated analysis of differentially expressed genes and construction of a competing endogenous RNA network in human Huntington neural progenitor cells
Tan, X., Liu, Y., Zhang, T., & Cong, S. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00894-2 · Cited by 4
Huntington’s Disease: From the Physiological Function of Huntingtin to the Disease
Borgs, L., Juliette, D. L., Malgrange, B., & Nguye, L. (2012) · InTech eBooks · doi:10.5772/31789 · Cited by 4
Retracted
Mitochondrial Calcium Signalling: Role in Oxidative Phosphorylation Diseases
Oulès, B., Prete, D., & Mouni, C. (2012) · InTech eBooks · doi:10.5772/32117 · Cited by 4
The biology of Huntington's disease
Saudou, F., & Humbert, S. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01257-2 · Cited by 4
Mitochondrial Membrane Potential and Dynamics
Oliveira, J. M. A. (2011) · Springer eBooks · doi:10.1007/978-0-85729-701-3_8 · Cited by 4
Aggregation in Huntington's disease: insights through modelling.
Čajavec, B., Bernard, S., & Herzel, H. (2005) · PubMed · Cited by 4
Therapeutic strategies in Huntington?s disease
Alberch, J., Canals, J. M., & Pérez‐Navarro, E. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.4.449 · Cited by 4
Les maladies neurodégénératives par expansion de polyglutamine : physiopathologie et stratégies thérapeutiques
Ravache, M., Sleymane, G. A., & Trottier, Y. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2009.12.004 · Cited by 5
Visualization of Muscle Activity During Squat Motion for Skill Education
Yanai, K., An, Q., Ishikawa, Y., Nakagawa, J., Wen, W., Yamakawa, H., Yamashita, A., & Asama, H. (2016) · Springer eBooks · doi:10.1007/978-4-431-55861-3_14 · Cited by 4
Huntington's disease: clinical and aetiologic aspects
(2006) · Schweizer Archiv für Neurologie und Psychiatrie · doi:10.4414/sanp.2006.01790 · Cited by 4
Oligomers and Cellular Toxicity
Kagan, B. L. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch14 · Cited by 4
Multitarget Drugs for Stabilization of Calcium Cycling and Neuroprotection in Neurodegenerative Diseases and Stroke
de Diego, A. M. G., Lorrio, S., Hernández-Guijo, J. M., Gandía, L., & de Diego, A. M. G. (2012) · Wiley eBooks · doi:10.1002/9781118185537.ch4 · Cited by 4
Correction: Ku70 Alleviates Neurodegeneration in Drosophila Models of Huntington's Disease
Tamura, T., Sone, M., Iwatsubo, T., Tagawa, K., Wanker, E. E., & Okazawa, H. (2012) · PLoS ONE · doi:10.1371/annotation/e436994f-3b22-4b35-bd29-49992f64a584 · Cited by 4
Antioxidant Nutraceuticals as Novel Neuroprotective Agents
Katiyar, P., Ghosh, S., Saini, S., Ghosh, C., Agrawal, H., Sircar, D., & Roy, P. (2022) · Wiley eBooks · doi:10.1002/9781119746843.ch8 · Cited by 4
Unraveling Neurodegeneration: Common Molecular Mechanisms and Novel Therapeutic Concepts in Major Neurodegenerative Disorders
Aldaghi, F. S., Siahpoosh, Z., Salehi, Z., Mashayekhi, F., & Sohrabnezhad, S. (2026) · Brain and Behavior · doi:10.1002/brb3.71615 · Cited by 3
Determination of neuroprotective effects of medium chain fatty acids and their derivatives on mutant huntingtin aggregates, oxidative stress and ATP levels in HD150Q cell line model of Huntington’s disease
Dabhi, R., Mehta, R., Paneri, J., Kakadiya, D., Shah, A., Singh, S., & Vijayvargia, R. (2023) · Indian Journal of Biochemistry and Biophysics · doi:10.56042/ijbb.v60i9.4047 · Cited by 3
Regulation of Mutant Huntingtin Mitochondrial Toxicity by Phosphomimetic Mutations within Its N-Terminal Region
Yablonska, S., Strohlein, C. E., Баранов, В. С., Yeh, S. M., Patel, A., Singh, T., Jauhari, A., Kim, J., Khattar, N. K., Li, F., et al. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.1254-24.2024 · Cited by 3
What Is the Role of Adenosine Tone and Adenosine Receptors in Huntington’s Disease?
Blum, D. L., Chern, E. C., Domenici, M. R., Buée, L., Lin, C. Y., Ferré, S., & Popoli, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_12 · Cited by 3
Energy Metabolism in Huntington’s Disease
Fabola, M., Dobránsky, T., Gervsio-Carvalho, E. A. D., Jader, S., & Fernando, A. (2012) · InTech eBooks · doi:10.5772/31610 · Cited by 3
Aggregate-centered redistribution of proteins by mutant huntingtin
Swayne, L. A., & Braun, J. E. A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.129 · Cited by 3
Biochemical and immunological aspects of protein aggregation in neurodegenerative diseases
Shojaei, F., Tavakolinia, N., Divsalar, A., Haertlé, T., Saboury, A. A., Nemat‐Gorgani, M., & Abbracchio, M. P. (2014) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-014-0491-x · Cited by 3
Huntington's disease
Kosinski, C. M., & Landwehrmeyer, G. B. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.058 · Cited by 3
A link between chromatin condensation mechanisms and Huntington's disease: connecting the dots
Lokhande, S., Patra, B. N., & Ray, A. (2016) · Molecular BioSystems · doi:10.1039/c6mb00598e · Cited by 5
Techniques for Simultaneous Mitochondrial and Cytosolic Ca2+ Imaging in Neurons
Rysted, J., Lin, Z., & Usachev, Y. M. (2017) · Neuromethods · doi:10.1007/978-1-4939-6890-9_8 · Cited by 3
HUNTINGTON DISEASE: CURRENT ADVANCES IN PATHOGENESIS AND RECENT THERAPEUTIC STRATEGIES
Wani, T. A., Al-Omara, M. A., & Zargar, S. (2011) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2011.030201 · Cited by 3
Trinucleotide-Expansion Diseases
Cooper, A. J. L., & Blass, J. P. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_11 · Cited by 3
Stress and Glucocorticoids as Experience-Dependent Modulators of Huntington's Disease
Mo, C., Renoir, T., & Hannan, A. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813146-6.00020-5 · Cited by 4
Mitochondrial Ca2+Transport in the Control of Neuronal Functions
Usachev, Y. M. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch4 · Cited by 3
Rhes Deletion Prevents Age-Dependent Selective Motor Deficits and Reduces Phosphorylation of S6K in Huntington Disease Hdh150Q(CAG) Knock-In MicePreprint
Hernandez, J., Shahani, N., Swarnkar, S., & Subramaniam, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.16.448681 · Cited by 3
Mitochondrial Function and Neurodegenerative Diseases
Wilkins, H. M., Weidling, I., Koppel, S., Wang, X., von Schulze, A., & Swerdlow, R. H. (2018) · The Molecular and Cellular Basis of Neurodegenerative Diseases · doi:10.1016/b978-0-12-811304-2.00013-4 · Cited by 2
Novel small molecule derivatives improve survivability in the cellular model of Huntington's disease via improving mitochondrial fusion
Kodam, P., Kumar, V., Pattanayak, P., Vitta, P., Chatterjee, T., & Maity, S. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00345h · Cited by 2
Preliminary observations of glucose metabolism dysregulation in pediatric Huntington’s disease
Graziola, F., Danti, F. R., Penzo, M., Spagarino, A., Minacapilli, E., Moscatelli, M. E. M., Zibordi, F., Mariotti, C., & Zorzi, G. S. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1626275 · Cited by 2
Copy Number Variation, Eicosapentaenoic Acid and Neurological Disorders. With Particular Reference to Huntington's Disease and Associated CAG Repeats, and to Myalgic Encephalomyelitis and Viral Infection
Puri, B. K., & Manku, M. S. (2010) · World review of nutrition and dietetics · doi:10.1159/000314507 · Cited by 2
Cysteamine in 3- nitropropionic acid model of Huntingtons disease in rats: Modulation of mitochondrial function and amino acid pattern
Abdelgawad, H. M., El-Abhar, H. S., & Arafa, N. M. S. (2009) · International Journal of Medicine and Medical Sciences · doi:10.5897/ijmms.9000067 · Cited by 2
Selective vulnerability in Huntington's disease: From excitotoxicity, mitochondrial dysfunction, and transcription dysregulation to therapeutic opportunity
Deyell, J., Gulia, R., & Spada, A. R. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00001-7 · Cited by 2
SYNTHETIC AROMATIC AGMATINE ANALOGS AS ALLOSTERIC MODULATORS OF THE N-METHYL-D-ASPARTATE (NMDA) RECEPTOR CHANNEL
Ring, J. R. (2006) · UKnowledge (University of Kentucky) · Cited by 2
Abnormal apocrine secretory cell mitochondria in a Huntington disease patient
Sidiropoulos, C., LeWitt, P. A., & Hashimoto, K. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.08.034 · Cited by 2
Growth Hormone Deteriorates the Functional Outcome in an Experimental Model of Huntington’s Disease Induced by 3-Nitropionic Acid
Park, J.-E., Lee, S., Im, W., & Kim, M. (2013) · Journal of Movement Disorders · doi:10.14802/jmd.13007 · Cited by 2
HUNTINGTON'S DISEASE
Barker, R. A., & Priller, J. (2003) · Brain · doi:10.1093/brain/awh011 · Cited by 2
The Swollen Optic Disc in Children
Brodsky, M. C. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3384-6_3 · Cited by 2
Huntington's disease
Wild, E. J., & Tabrizi, S. J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139087711.006 · Cited by 2
Protein Aggregation, Ion Channel Formation, and Membrane Damage
Kagan, B. L. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_11 · Cited by 2
Huntington disease
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00014-7 · Cited by 2
Metal Biology Associated with Huntington’s Disease
Bichell, T. J., Halbesma, T. C., Tipps, K. G., & Bowman, A. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00013-0 · Cited by 2
Neuropathology of Movement Disorders
Jellinger, K. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00076-9 · Cited by 2
Trafficking Defects in Huntington's Disease
Trushina, E. V., & McMurray, C. T. (2007) · Elsevier eBooks · doi:10.1016/b978-012369437-9/50024-4 · Cited by 2
Mechanistic Insights into the Polyglutamine Ataxias
Miller, V. M., & Paulson, H. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_23 · Cited by 2
Huntington's Disease and Other Choreas
Salman, H., Wild, E. J., & Tabrizi, S. J. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch21 · Cited by 2
Huntingtin preserves mitochondrial genome integrity in neurons, which is impaired in Huntington’s diseasePreprint
Pradhan, S., Gaikwad, S., Tsai, C.-L., Smith-Geater, C., Zhang, N., Bush, K. M., Chakraborty, A., Yuan, S., Choudhary, S., Keene, C. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.24.666629 · Cited by 2
Plate-Based Assays for the Characterization of Mitochondrial and Cellular Phenotypes
Arnold, B. H., Sanislav, O., Fisher, P. R., & Annesley, S. J. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3585-8_1 · Cited by 1
Leucine 7 is a key residue for mutant huntingtin–induced mitochondrial pathology and neurotoxicity in Huntington's disease
Zhang, S., Wang, S., Yang, Z., Li, Y., Li, J., Chen, X., Yao, H., Zheng, Z., & Guo, X. L. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108297 · Cited by 1
Exocytosis, Mitochondrial Injury and Oxidative Stress in Neurodegenerative Diseases
Zanin, M., & Keating, D. J. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_4 · Cited by 1
Sirtuins and mitochondrial dysfunction
He, J., Wang, T.-S., & Wang, Y.-P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822467-0.00007-3 · Cited by 2
Lipid composition controls the huntingtin exon 1 membrane‐association and differentially modulates its flanking regions' dynamics
Sousa, T., Damas, G., Coutinho, A., Bernardes, N., Azevedo, A. S., PRIETO, M. J. E., & Melo, A. M. (2026) · Protein Science · doi:10.1002/pro.70612 · Cited by 1
Nosological structure and frequency of autosomal dominant spinocerebellar ataxias associated with nucleotide repeat expansions in Russia
Vuta, E. V., Nazarov, V. D., Sidorenko, D. V., Банина, Д. Ю., Lapin, S. V., & Маzing, A. V. (2025) · Neuromuscular Diseases · doi:10.17650/2222-8721-2025-15-3-10-21 · Cited by 1
Dysregulation of arginase and arginine pathways in neurodegenerative diseases: Metabolic and cellular dysfunction and therapeutic implications
Nalepa, M., Skweres, A., & Węgrzynowicz, M. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.05.285 · Cited by 1
Molecular mechanisms, clinical phenotypes, and advances in Huntington’s disease therapeutics
Sarath, A. M., Thapliyal, D., Borthakur, S., Chakraborty, D., Singh, N. T., Sarkar, R., & Singh, M. D. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00282-5 · Cited by 1
Allele-Specific Conditional Destabilization of Glutamine Repeat mRNAs
Crouse, A. B., & Detloff, P. J. (2005) · Gene Expression · doi:10.3727/000000005783992089 · Cited by 1
Modeling Huntington Disease in Yeast and Invertebrates
Mason, R. P., Breda, C., Kooner, G. S., Mallucci, G. R., Kyriacou, C. P., & Giorgini, F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405195-9.00033-0 · Cited by 2
Mitochondrial DNA variation in extremely selected traits: longevity and elite athletic performance
Niemi, A. (2005) · Cited by 1
Neuronal calcium dynamics
Fendyur, A., Kaiserman, I., & Rahamimoff, R. (2004) · CRC Press eBooks · doi:10.3109/9780203493878-14 · Cited by 1
Brain Region and Cell Compartment Dependent Regulation of Electron Transport System Components in Huntington’s Disease Model Mice
Burtscher, J., Pepe, G., Marracino, F., Capocci, L., Giova, S., Millet, G. P., Pardo, A. D., & Maglione, V. (2021) · Brain Sciences · doi:10.3390/brainsci11101267 · Cited by 1
Mitochondrial Dysfunction in Brain and Muscle Pathology of Huntington’s Disease
Rivera, S., McMurray, C. T., & Ayala‐Peña, S. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_133 · Cited by 1
Mitochondrial Dynamics and Huntington’s Disease: A Dance of Fate
Wang, H., Karbowski, M., & Monteiro, M. J. (2011) · Springer eBooks · doi:10.1007/978-94-007-1291-1_9 · Cited by 1
Huntington disease
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00013-5 · Cited by 1
Systems biology study of Huntington's disease
Dionisio, L. E., Langfelder, P., Aaronson, J. S., Rosinski, J., & Yang, X. W. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95672-7.00006-6 · Cited by 1
The effects of Rhes, a striatal specific protein, on the expression of behavioral and neuropathological symptoms in a transgenic mouse model of Huntington's disease
Baiamonte, B. A. (2012) · ScholarWorks @ The University of New Orleans (The University of New Orleans) · Cited by 1
Mitochondrial DNA in neurons and its modulation by neurotoxins
Santos, M. S. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Metabolic Alterations Amalgamated with Huntington’s Disease
Lakra, P., & Agrawal, N. (2019) · Springer eBooks · doi:10.1007/978-981-13-2218-1_6 · Cited by 1
Neurotoxicity in Huntington Disease
Loy, C. T., & Hannan, A. J. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_140 · Cited by 1
Efficacy of Phytochemicals and Natural Products in the Management/Treatment of Neurodegenerative Diseases
Oladele, J. O., Oladele, O. T., Adewole, T. S., Oyeleke, O. M., & Oladiji, A. T. (2022) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5129-8.ch010 · Cited by 1
How molecular imaging studies can disentangle disease mechanisms in age-related neurodegenerative disorders
de Natale, E. R., Wilson, H., Udeh‐Momoh, C. T., Ford, J. K., Politis, M., & Middleton, L. T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00022-7 · Cited by 1
Neurotoxicity in Huntington Disease
Loy, C. T., & Hannan, A. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_140 · Cited by 1
Mitochondrial Ca2+ Dysregulation During Stroke and Cell Death
Sisalli, M. J., Savoia, C., & Scorziello, A. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9663-3_3 · Cited by 1

Authors: Panov, A. V., Gutekunst, C.-A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., & Greenamyre, J. T.
Affiliations: Emory University (US)
University of British Columbia (CA)
Duke Medical Center (US)
Corresponding author: Greenamyre, J. Timothy
ORCID: Panov, Alexander V.
Gutekunst, Claire-Anne
Leavitt, Blair R.
Hayden, Michael R.
Burke, James R.
Greenamyre, J. Timothy
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2002-07-01
Volume: 5
Issue: 8
Pages: 731-736
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/nn884
OpenAlex: W1972771185
Cited by: 1,030
References: 35
Citations by year: 2026: 16 · 2025: 23 · 2024: 26 · 2023: 27 · 2022: 30 · 2021: 49 · 2020: 29 · 2019: 35 · 2018: 39 · 2017: 23 · 2016: 45 · 2015: 35 · 2014: 48 · 2013: 33 · 2012: 68
FWCI: 19.24
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ag014648-05)
National Institute on Aging (AG14648)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
Keywords: Huntington's disease, mitochondrial calcium handling, polyglutamine expansion, mutant huntingtin, mitochondrial membrane potential, mitochondrial depolarization, neurodegeneration, transgenic mice, early pathogenesis
MeSH terms: Huntingtin Protein, Animals, Brain, Brain Chemistry, Calcium, Cell Line, Disease Models, Animal, Humans, Huntington Disease, Intracellular Membranes, Lymphocytes, Membrane Potentials, Mice, Transgenic, Microscopy, Electron, Mitochondria, Nerve Tissue Proteins, Nuclear Proteins, Recombinant Fusion Proteins, Trinucleotide Repeat Expansion, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks